Cargando…

2018 Korean society of hypertension guidelines for the management of hypertension: part III-hypertension in special situations

Treatment of hypertension improves cardiovascular, renal, and cerebrovascular outcomes. However, the benefit of treatment may be different according to the patients’ characteristics. Additionally, the target blood pressure or initial drug choice should be customized according to the special conditio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Kwang-il, Ihm, Sang-Hyun, Kim, Gheun-Ho, Kim, Hyeon Chang, Kim, Ju Han, Lee, Hae-Young, Lee, Jang Hoon, Park, Jong-Moo, Park, Sungha, Pyun, Wook Bum, Shin, Jinho, Chae, Shung Chull
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6670160/ https://www.ncbi.nlm.nih.gov/pubmed/31388452 http://dx.doi.org/10.1186/s40885-019-0123-y

Ejemplares similares

2018 Korean Society of Hypertension guidelines for the management of hypertension: part I-epidemiology of hypertension
por: Kim, Hyeon Chang, et al.
Publicado: (2019)

2018 Korean Society of Hypertension Guidelines for the management of hypertension: part II-diagnosis and treatment of hypertension
por: Lee, Hae-Young, et al.
Publicado: (2019)

2013 Korean Society of Hypertension guidelines for the management of hypertension: part III-hypertension in special situations
por: Shin, Jinho, et al.
Publicado: (2015)

2013 Korean Society of Hypertension guidelines for the management of hypertension. Part II—treatments of hypertension
por: Shin, Jinho, et al.
Publicado: (2015)

2013 Korean Society of Hypertension guidelines for the management of hypertension: part I–epidemiology and diagnosis of hypertension
por: Shin, Jinho, et al.
Publicado: (2015)

The 2022 focused update of the 2018 Korean Hypertension Society Guidelines for the management of hypertension
por: Kim, Hack-Lyoung, et al.
Publicado: (2023)

Statement on chronotherapy for the treatment of hypertension: consensus document from the Korean society of hypertension
por: Park, Sungha, et al.
Publicado: (2023)

Resistant hypertension: consensus document from the Korean society of hypertension
por: Park, Sungha, et al.
Publicado: (2023)

Higher Blood Pressure Variability in White Coat Hypertension; from the Korean Ambulatory Blood Pressure Monitoring Registry
por: Kang, In Sook, et al.
Publicado: (2016)

Smartphone / smartwatch-based cuffless blood pressure measurement : a position paper from the Korean Society of Hypertension
por: Lee, Hae Young, et al.
Publicado: (2021)

The Association between Parameters of Socioeconomic Status and Hypertension in Korea: the Korean Genome and Epidemiology Study
por: Park, Chan Soon, et al.
Publicado: (2016)

Clinical and life style factors related to the nighttime blood pressure, nighttime dipping and their phenotypes in Korean hypertensive patients
por: Kim, Byung Sik, et al.
Publicado: (2023)

Clinical features and predictors of masked uncontrolled hypertension from the Korean Ambulatory Blood Pressure Monitoring Registry
por: Kim, Hyun-Jin, et al.
Publicado: (2021)

Home blood pressure monitoring: a position statement from the Korean Society of Hypertension Home Blood Pressure Forum
por: Ihm, Sang-Hyun, et al.
Publicado: (2022)

Suboptimal Management Status of Younger Hypertensive Population in Korea
por: Lee, Hae-Young, et al.
Publicado: (2021)

Erratum to: Prevalence of resistant hypertension and associated factors for blood pressure control status using Korean ambulatory blood pressure monitoring registry data
por: Choi, Sung Il, et al.
Publicado: (2016)

Transition of May Measurement Month to an online hypertension awareness campaign in Korea during the COVID-19 pandemic
por: Shin, Jinho, et al.
Publicado: (2021)

Prevalence of resistant hypertension and associated factors for blood pressure control status with optimal medical therapy using Korean ambulatory blood pressure monitoring registry data
por: Choi, Sung Il, et al.
Publicado: (2016)

Fimasartan versus perindopril with and without diuretics in the treatment of elderly patients with essential hypertension (Fimasartan in the Senior Subjects (FITNESS)): study protocol for a randomized controlled trial
por: Kang, Min-gu, et al.
Publicado: (2019)

24-Hour blood pressure response to lower dose (30 mg) fimasartan in Korean patients with mild to moderate essential hypertension
por: Lee, Hae-Young, et al.
Publicado: (2017)

Metabolic syndrome, not menopause, is a risk factor for hypertension in peri-menopausal women
por: Oh, Gyu Chul, et al.
Publicado: (2018)

Efficacy of a fixed dose combination of irbesartan and atorvastatin (Rovelito(®)) in Korean adults with hypertension and hypercholesterolemia
por: Ihm, Sang-Hyun, et al.
Publicado: (2019)

Temporal and Geospatial Trends of Hypertension Management in Korea: a Nationwide Study 2002–2016
por: Lee, Hokyou, et al.
Publicado: (2019)

Potential impact of 2018 Korean Society of Hypertension guidelines on Korean population: a population-based cohort study
por: Kwun, Ju-Seung, et al.
Publicado: (2020)

Cost-Effectiveness Analysis of Hypertension Screening in the Korea National Health Screening Program
por: Lee, Hae-Young, et al.
Publicado: (2021)

Low-Dose Triple Antihypertensive Combination Therapy in Patients with Hypertension: A Randomized, Double-Blind, Phase II Study
por: Hong, Soon Jun, et al.
Publicado: (2020)

Disparities in Mortality and Cardiovascular Events by Income and Blood Pressure Levels Among Patients With Hypertension in South Korea
por: Shin, Jeong‐Hun, et al.
Publicado: (2021)

Long-term cardiovascular events in hypertensive patients: full report of the Korean Hypertension Cohort
por: Lee, Jin Young, et al.
Publicado: (2023)

Korea hypertension fact sheet 2018
por: Kim, Hyeon Chang, et al.
Publicado: (2018)

Office blood pressure threshold of 130/80 mmHg better predicts uncontrolled out‐of‐office blood pressure in apparent treatment‐resistant hypertension
por: Lee, Chan Joo, et al.
Publicado: (2020)

Office Blood Pressure Range and Cardiovascular Events in Patients With Hypertension: A Nationwide Cohort Study in South Korea
por: Kwon, Chang Hee, et al.
Publicado: (2021)

Incidence of Hypertension in Korea: 5-Year Follow-up Study
por: Lee, Jang Hoon, et al.
Publicado: (2011)

Comparison of efficacy and safety between third‐dose triple and third‐dose dual antihypertensive combination therapies in patients with hypertension
por: Sung, Ki‐Chul, et al.
Publicado: (2023)

Differential Control Rate of Systolic and Diastolic Blood Pressure among Korean Adults with Hypertension: the Sixth Korean National Health and Nutrition Examination Survey, 2013–2015 (KNHANES VI)
por: Cho, So Mi Jemma, et al.
Publicado: (2019)

Korea hypertension fact sheet 2021: analysis of nationwide population-based data with special focus on hypertension in women
por: Kim, Hyeon Chang, et al.
Publicado: (2022)

Impact of 2018 ESC/ESH and 2017 ACC/AHA Hypertension Guidelines: Difference in Prevalence of White-Coat and Masked Hypertension
por: Kim, Byong-Kyu, et al.
Publicado: (2020)

Korea hypertension fact sheet 2022: analysis of nationwide population-based data with a special focus on hypertension in the elderly
por: Kim, Hyeon Chang, et al.
Publicado: (2023)

Combined Effect of Income and Medication Adherence on Mortality in Newly Treated Hypertension: Nationwide Study of 16 Million Person‐Years
por: Lee, Hokyou, et al.
Publicado: (2019)

Status of hypertension screening in the Korea National General Health Screening Program: a questionnaire survey on 210 screening centers in two metropolitan areas
por: Lee, Seung Won, et al.
Publicado: (2017)

The Korean Hypertension Cohort study: design and baseline characteristics
por: Lee, Hae-Young, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f0k1v4o5fchpv88ks6pfcdoneu